2050-4-23 Viral Lab Report
From: Autogenomic Labs
To: Global Health Council
cc: NuvoPharm, EnterLabs
Re: PNDV-1 Surging We have seen a significant uptick in cases of PNDV-1 in many regions. While not at a pandemic state, we have yet to find a vaccine or treatment that can effectively counter the virus. We believe that this virus is capable of transmission not only through airborne means, but also through contact with bodily fluids. If this is confirmed, it may require new protocols for transmission reduction. At this time, we do not recommend chagning protocols, but we must keep an eye on the spread. We have copied this email to two other labs who have been researching the virus. Sequencing of this virus is a high priority, as we do not have a viable method of treatment or prevention. Dr. Thea Longstreet, PhD
Autogenomic Labs
To: Global Health Council
cc: NuvoPharm, EnterLabs
Re: PNDV-1 Surging We have seen a significant uptick in cases of PNDV-1 in many regions. While not at a pandemic state, we have yet to find a vaccine or treatment that can effectively counter the virus. We believe that this virus is capable of transmission not only through airborne means, but also through contact with bodily fluids. If this is confirmed, it may require new protocols for transmission reduction. At this time, we do not recommend chagning protocols, but we must keep an eye on the spread. We have copied this email to two other labs who have been researching the virus. Sequencing of this virus is a high priority, as we do not have a viable method of treatment or prevention. Dr. Thea Longstreet, PhD
Autogenomic Labs
Remove these ads. Join the Worldbuilders Guild
Comments